Drug Shortage Report for CILOXAN
| Report ID | 169228 |
| Drug Identification Number | 01945270 |
| Brand name | CILOXAN |
| Common or Proper name | CILOXAN 0.3% SOLUTION |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CIPROFLOXACIN |
| Strength(s) | 0.3% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S03AA |
| ATC description | ANTIINFECTIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-09-14 |
| Actual start date | 2022-09-14 |
| Estimated end date | Unknown |
| Actual end date | 2022-10-06 |
| Shortage status | Resolved |
| Updated date | 2022-10-07 |
| Company comments | Release of Lot# 117A9 on Oct 6th |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-10-07 | French | Compare |
| v4 | 2022-10-07 | English | Compare |
| v3 | 2022-09-15 | English | Compare |
| v2 | 2022-09-14 | French | Compare |
| v1 | 2022-09-14 | English | Compare |
Showing 1 to 5 of 5